Monday, December 23, 2024
HomeTagsCirculating tumor DNA

circulating tumor DNA

Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy

Guardant Health, Inc, a leading precision oncology company, announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX),...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics